Additionally, loss of TREM2 via global knockout or anti-TREM2 neutralizing antibodies improves T cell responses, similar to anti-PD-1 immunotherapy, and ultimately reduced tumor size in a macrophage-dependent manner59. This evidence concerns the gene PDCD1 and neoplasm.